SLC30A7

Zinc transporter 7 · Q8NEW0 · SLC30A7 on Sugi Atlas →

0 patent compounds predicted against SLC30A7, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SLC30A7 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated Pregnancies PHASE4COMPLETED
Delivery of Iron and Zinc Supplements: Evaluation of Interaction Effect on Biochemical and Clinical Outcomes PHASE4COMPLETED
Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus PHASE3COMPLETED
Safety and Dose Escalation Study of Zinc Supplementation in Critically Ill Children PHASE1/PHASE2COMPLETED
Oral N-acetylglucosamine in Crohn's Disease PHASE2NOT_YET_RECRUITING
Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D PHASE2WITHDRAWN
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors PHASE1RECRUITING
A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 Diabetes PHASE1COMPLETED
A Study to Assess the Effect of Itraconazole Capsules on the Pharmacokinetics of ZX-7101A Tablets in Healthy Adult Subjects in China PHASE1COMPLETED
Randomized Clinical Trial: IS Zinc and Zinc Ionophere EGCG as Supplement Improve Outcome of Active Pulmonary Tuberculosis PHASE1UNKNOWN
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism EARLY_PHASE1UNKNOWN
Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes EARLY_PHASE1RECRUITING
Zn Supplementation in HIV Immunological Non Responders nanRECRUITING
Nutrigenomics of Zinc Supplementation in Insulin Secretion and Diabetes nanCOMPLETED
Zinc and Diabetes in Patients With Thalassemia: a Pilot Study nanCOMPLETED
Zinc Sulfate Acceptability nanCOMPLETED
Serum Zinc and Serum Magnesium in Chronic Liver Disease Patients nanCOMPLETED
Exchangeable Zinc Pool Size and Zn Absorption From Sprinkles and Traditional Foods in Pakistani Infants /Toddlers nanCOMPLETED
Determination of Pre-Absorptive Dissociation of Zinc From a Zinc Amino Acid Complex in Healthy Men nanCOMPLETED
Zinc and the Synthesis of Zinc Binding Proteins (Protocol B) nanCOMPLETED
Role of the ATP7A Transporter in Ovarian Cancer nanCOMPLETED
UK Islet Autoantibody Registry nanRECRUITING
Newborn Screening for Genetic Susceptibility to Type 1 Diabetes and Celiac Disease and Prospective Follow-up Study nanACTIVE_NOT_RECRUITING
Copper Supplementation in Cirrhosis nanRECRUITING
A Controlled Study of Potential Therapeutic Effect of Oral Zinc in Manifesting Carriers of Wilson Disease nanUNKNOWN
Gene Expression in Inflammatory Bowel Disease nanENROLLING_BY_INVITATION
Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF) nanCOMPLETED
An Evaluation of Zinc Status Biomarkers nanCOMPLETED
Oral Zinc for the Treatment of Acute Diarrhea in US Children nanCOMPLETED
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SLC30A7 binder may also engage these)

ProteinNameSimilarity
Q5BJM8 1.000 Q5BJM8 →
A4IFD7 1.000 A4IFD7 →
Q9JKN1 1.000 Q9JKN1 →
Q52KD7 1.000 Q52KD7 →
Q6NRI1 0.998 Q6NRI1 →
Q5MNV6 0.996 Q5MNV6 →
Q6P3N9 0.993 Q6P3N9 →
A5PMX1 0.992 A5PMX1 →
O13918 0.987 O13918 →
O45923 0.987 O45923 →
Q8H329 0.983 Q8H329 →
P20107 0.981 P20107 →
Q5XHB4 0.981 Q5XHB4 →
P32798 0.980 P32798 →
Q9SI03 0.979 Q9SI03 →
Q6QIX3 0.979 Q6QIX3 →
Q2HJ10 0.978 Q2HJ10 →
Q9TTF3 0.978 Q9TTF3 →
Q5I020 0.978 Q5I020 →
O14863 0.978 O14863 →
Q8IWU4 0.978 Q8IWU4 →
O35149 0.977 O35149 →
Q62941 0.977 Q62941 →
Q8BGG0 0.977 Q8BGG0 →
P97441 0.976 P97441 →
O55174 0.974 O55174 →
Q9VAF0 0.974 Q9VAF0 →
Q9BRI3 0.973 Q9BRI3 →
Q6DBM8 0.973 Q6DBM8 →
A8WMY3 0.973 A8WMY3 →